The association of high ZNF154 expression with improved overall survival was also validated in a cohort of 53 laryngeal squamous cell carcinoma patients undergoing treatment with curative intent as part of the earlier Albert Einstein College of Medicine Head and Neck Cancer cohort (Log-rank, p < 0.05) (Additional file 2: Fig. S2). This evidence concerns the gene ZNF154 and head and neck cancer.